Clinical Trials Logo

Lipid Metabolism, Inborn Errors clinical trials

View clinical trials related to Lipid Metabolism, Inborn Errors.

Filter by:

NCT ID: NCT00477594 Completed - Clinical trials for Hypercholesterolemia

Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia

Start date: May 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of extended dosing of mipomersen in patients with familial hypercholesterolemia on lipid-lowering therapy who have completed either the 301012-CS8 (NCT00280995) or 301012-CS9 (NCT00281008) clinical drug trials.

NCT ID: NCT00362180 Completed - Clinical trials for Hypercholesterolemia

Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration

Start date: July 2006
Phase: Phase 2
Study type: Interventional

This study will assess what, if any, effect that ISIS 301012 (mipomersen) has on liver triglyceride content in multiple groups of subjects with varying degrees of risk for hepatic steatosis. In order to enroll subject groups with varying degrees of risk, the study has included multiple cohorts (Cohorts A-G). Additions and removal of cohorts has been accomplished with protocol amendments.

NCT ID: NCT00092898 Completed - Heart Disease Clinical Trials

An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED)

Start date: October 2004
Phase: Phase 3
Study type: Interventional

This is a 6-month study with patients who have the rare disease, sitosterolemia which may result in heart-related diseases. These patients have unusually high absorption of non-cholesterol sterols, resulting in heart-related diseases. This study investigates whether absorption of these non-cholesterols can be reduced in these patients.

NCT ID: NCT00092820 Completed - Heart Disease Clinical Trials

Sitosterolemia Extension Study (0653-004)(COMPLETED)

Start date: February 12, 2001
Phase: Phase 3
Study type: Interventional

This is an extension study for patients having unusually high absorption of non-cholesterol sterols, resulting in heart-related diseases. This study will evaluate the long term safety and the ability to lower cholesterol levels with an investigational drug.

NCT ID: NCT00092807 Completed - Heart Disease Clinical Trials

Sitosterolemia Extension Study (0653-003)(COMPLETED)

Start date: February 12, 2001
Phase: Phase 3
Study type: Interventional

This is an extension study for patients having unusually high absorption of non-cholesterol sterols, resulting in heart-related diseases. This study will evaluate the long term safety and the ability to lower cholesterol levels with an investigational drug.

NCT ID: NCT00004481 Completed - Clinical trials for Lipid Metabolism, Inborn Errors

Genetic Study of Sitosterolemia

Start date: November 1999
Phase: N/A
Study type: Observational

OBJECTIVES: I. Identify the genetic defect and fine map the gene that causes sitosterolemia.